Completed NCT02642926
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Other Over 18 Years
Countries France
Sponsor Brugmann University Hospital
Condition Bipolarity Completed NCT00261443
This study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug i A study involving a medication or substance. Over 18 Years
Countries United States, France, Brazil, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity Completed NCT00490971
This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States, France, Bulgaria, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Bipolarity Completed NCT04034147
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 65 Years
Countries France
Sponsor Versailles Hospital
Condition Bipolarity Terminated NCT02472483
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 18 Years to 65 Years
Countries France
Sponsor Centre Hospitalier St Anne
Condition Bipolarity Completed NCT05922956
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Other Over 18 Years
Countries France
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Bipolarity Completed NCT02794129
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Other From 18 Years to 65 Years
Countries France
Sponsor CHU de Reims
Condition Bipolarity Completed NCT01710709
This study is completed in the United States, in France, in Canada, .... It is testing intramuscular Formulation of Aripiprazole for Bipolarity.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States, France, Canada, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity Unknown NCT06497868
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Observational Over 18 Years
Countries France
Sponsor University Hospital, Strasbourg, France
Condition Bipolarity Active Not Recruiting NCT03245593
This study is looking at care and outcomes for people with bipolarity. Taking part may give some people access to Shared-decision making process, but direct benefit is not guaranteed.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Other Over 18 Years
Countries France
Sponsor Centre Hospitalier Universitaire de Nīmes
Condition Bipolarity Completed NCT00126009
This summary needs review. Please check the official study record and contact the research team for details.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries France, Czechia, Poland, ...
Sponsor Sanofi
Condition Bipolarity Completed NCT01575561
This study is completed in the United States, in France, in Argentina, .... It is testing lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for Bipolarity.
In France Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug Over 18 Years
Countries United States, France, Argentina, ...
Sponsor Sumitomo Pharma America, Inc.
Condition Bipolarity